Jiangsu Gdk Biological Technology Co., Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 127.14 million compared to CNY 16.4 million a year ago. Revenue was CNY 127.14 million compared to CNY 16.4 million a year ago.

Net income was CNY 35.08 million compared to net loss of CNY 17.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to basic loss per share from continuing operations of CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to diluted loss per share from continuing operations of CNY 0.14 a year ago.